HIV1 protease inhibitors selectively induce inflammatory chemokine expression in primary human osteoblasts

Andrea P. Malizia, Mihai H. Vioreanu, Peter P. Doran, William G. Powderly

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

HIV-infected patients are at increased risk of decreased bone mineral density. Several studies have implicated antiretroviral therapy as a contributor to the decreased bone mineral density seen in treated HIV-1 patients. Whilst the exact molecular mechanisms underlying decreased bone density remain to be elucidated, inflammation has been postulated to be an important pathogenomic mechanism. In this study, we have explored primary human osteoblast gene expression in response to protease inhibitors (PIs), by oligonucleotide microarray analysis. A list of dysregulated genes, correlated with the inflammatory response, increased significantly after NFV and RTV exposure. Analysis of gene and protein expression determined a selectively increase of the pro-inflammatory cytokines monocyte chemoattractant protein (MCP)-1 and interleukin-8 (IL-8) following exposure to a pharmacological concentration of NFV and RTV. These data suggested that generation of local inflammatory cascades may contribute to the development of decreased bone mineral density in highly active antiretroviral therapy (HAART)-treated HIV patients.

Original languageEnglish
Pages (from-to)72-76
Number of pages5
JournalAntiviral Research
Volume74
Issue number1
DOIs
StatePublished - Apr 2007

Keywords

  • HAART
  • IL-8
  • Inflammation
  • MCP-1
  • Nelfinavir
  • Osteoblasts
  • Ritonavir

Fingerprint

Dive into the research topics of 'HIV1 protease inhibitors selectively induce inflammatory chemokine expression in primary human osteoblasts'. Together they form a unique fingerprint.

Cite this